MARKET

RTRX

RTRX

Retrophin
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.77
-0.08
-0.62%
After Hours: 12.77 0 0.00% 16:00 11/11 EST
OPEN
12.79
PREV CLOSE
12.85
HIGH
12.91
LOW
12.48
VOLUME
207.49K
TURNOVER
--
52 WEEK HIGH
26.80
52 WEEK LOW
10.87
MARKET CAP
548.58M
P/E (TTM)
-4.3403
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RTRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RTRX News

  • The Zacks Analyst Blog Highlights: LHC, Retrophin, Dermira and Merck & Co
  • Zacks.3d ago
  • Top Ranked Momentum Stocks to Buy for November 7th
  • Zacks.4d ago
  • Trade Deal Delay Unlikely to Hit U.S. Healthcare: 4 Picks
  • Zacks.4d ago
  • Edited Transcript of RTRX earnings conference call or presentation 30-Oct-19 8:30pm GMT
  • Thomson Reuters StreetEvents.10/31 07:39

More

Industry

Biotechnology & Medical Research
-0.51%
Pharmaceuticals & Medical Research
-0.43%

Hot Stocks

Name
Price
%Change

About RTRX

Retrophin, Inc. is a biopharmaceutical company. The Company is focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases. The Company sells three products, including Chenodal (chenodeoxycholic acid), Cholbam (cholic acid) and Thiola (tiopronin). Its Chenodal is approved in the United States for the treatment of patients suffering from gallstones in whom surgery poses an unacceptable health risk due to disease or advanced age. Chenodal has also been care for cerebrotendinous xanthomatosis (CTX) patients. Its Cholbam is approved in the United States for the treatment of bile acid synthesis disorders due to single enzyme defects and is further indicated for adjunctive treatment of patients with peroxisomal disorders. Its Thiola is approved in the United States for the prevention of cystine (kidney) stone formation in patients with severe homozygous cystinuria.
More

Webull offers Retrophin Inc (RTRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.